These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 17102106
1. Current trends in functional imaging of pheochromocytomas and paragangliomas. Shulkin BL, Ilias I, Sisson JC, Pacak K. Ann N Y Acad Sci; 2006 Aug; 1073():374-82. PubMed ID: 17102106 [Abstract] [Full Text] [Related]
2. Imaging of Pheochromocytomas and Paragangliomas. Timmers HJLM, Taïeb D, Pacak K, Lenders JWM. Endocr Rev; 2024 May 07; 45(3):414-434. PubMed ID: 38206185 [Abstract] [Full Text] [Related]
3. Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma. Timmers HJ, Taieb D, Pacak K. Horm Metab Res; 2012 May 07; 44(5):367-72. PubMed ID: 22399235 [Abstract] [Full Text] [Related]
4. Pheochromocytoma and paraganglioma: imaging characteristics. Baez JC, Jagannathan JP, Krajewski K, O'Regan K, Zukotynski K, Kulke M, Ramaiya NH. Cancer Imaging; 2012 May 07; 12(1):153-62. PubMed ID: 22571874 [Abstract] [Full Text] [Related]
6. New functional imaging modalities for chromaffin tumors, neuroblastomas and ganglioneuromas. Ilias I, Shulkin B, Pacak K. Trends Endocrinol Metab; 2005 Mar 07; 16(2):66-72. PubMed ID: 15734147 [Abstract] [Full Text] [Related]
7. Novel use of F-DOPA PET/CT imaging in a child with paraganglioma/pheochromocytoma syndrome. Levine DS, Metzger DL, Nadel HR, Oviedo A, Adam MJ, Skarsgard E. Pediatr Radiol; 2011 Oct 07; 41(10):1321-5. PubMed ID: 21567141 [Abstract] [Full Text] [Related]
8. Is there an optimal scan time for 6-[F-18]fluoro-L-DOPA PET in pheochromocytomas and paragangliomas? Hentschel M, Rottenburger C, Boedeker CC, Neumann HP, Brink I. Clin Nucl Med; 2012 Feb 07; 37(2):e24-9. PubMed ID: 22228360 [Abstract] [Full Text] [Related]
9. MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas. van Gils AP, Falke TH, van Erkel AR, Arndt JW, Sandler MP, van der Mey AG, Hoogma RP. Radiographics; 1991 Jan 07; 11(1):37-57. PubMed ID: 1671719 [Abstract] [Full Text] [Related]
10. Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Ling A, Eisenhofer G, Adams KT, Solis D, Lenders JW, Pacak K. J Clin Oncol; 2007 Jun 01; 25(16):2262-9. PubMed ID: 17538171 [Abstract] [Full Text] [Related]
11. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations. Zelinka T, Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Reynolds JC, Ling A, Eisenhofer G, Lazúrová I, Adams KT, Whatley MA, Widimsky J, Pacak K. Endocr Relat Cancer; 2008 Mar 01; 15(1):311-23. PubMed ID: 18310297 [Abstract] [Full Text] [Related]
12. [11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma. Mann GN, Link JM, Pham P, Pickett CA, Byrd DR, Kinahan PE, Krohn KA, Mankoff DA. Ann Surg Oncol; 2006 Feb 01; 13(2):187-97. PubMed ID: 16418883 [Abstract] [Full Text] [Related]